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Abstract 
Hypertension is predominantly detected and managed in primary or community care 
settings. Nurses are key members of the multidisciplinary primary care team, and are 
commonly involved in measuring or managing blood pressure. Nurses undertake a range of 
tasks in hypertension care and many randomised controlled trials of different nurse led 
interventions have been conducted, providing evidence from different populations. There is 
good evidence to support better blood pressure outcomes when nurses deliver care face to 
face, but not remotely. Other important components of these complex interventions appear 
to be the inclusion of a structured care algorithm, ability to prescribe or altering 
medications, and maintaining contact at least monthly until blood pressure is controlled to 
target. There is limited reporting of the costs of interventions and evidence for cost 
effectiveness of nurse led care compared to usual care is lacking, and there is no clear 
evidence from longer term follow up of the effect of nurse led interventions on 
cardiovascular outcomes. The design of programmes for nurse led care in hypertension 
should take account of the existing evidence and areas of uncertainly. Nurses generally work 
within teams and future studies of team approaches to hypertension, either including or led 
by nurses, are needed. Any future studies of nurse led care should include a robust cost 
effectiveness analysis. 
 
__________________________________________________________________________________ 
1.1 Introduction 
Raised blood pressure is the main risk factor globally for premature morbidity and 
mortality.1 Globally it affected close to one billion adults (26% of the population) in 2000, 
and is projected to rise to 1.6 billion by 2025.2 This makes measurement of  blood pressure a 
common reason for consultation in primary care,3 and rising workload and availability of 
doctors in primary care is an international concern.4,5 In English primary care consultation 
rates for general practitioners rose by 13.6% over the seven years to 2014, whilst rates for 
nurses rose by only 0.9% during the same period.6 It is suggested that transfer of some 
clinical roles from doctors to nurses may help to alleviate the growing workforce crisis, and 
reviews suggest that appropriately trained nurses can deliver care with the same quality and 
outcomes as doctors.7 
A 10 mmHg reduction in systolic blood pressure is estimated to achieve a 41% reduction in 
stroke and a 22% reduction in coronary heart disease.8 Whilst blood pressure control is 
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improving over time the detection and adequate management of high blood pressure 
remains a challenge.9 Nurse led care in hypertension is seen as one means of improving 
implementation of guidelines on blood pressure management.10,11 Resource limitations also 
encourage substitution of doctors by nurses and other allied health professionals in the 
belief that they are less costly,12 however it continues to be noted that the evidence for this 
is too limited to support such conclusions.13  
 
1.2 Nurse substitution in hypertension  
Trials of nurse led care have been appearing since the 1990s,14-16 however Oakeshott 
concluded in her 2003 systematic review that there was a lack of robust evidence of 
effectiveness for nurse led care in hypertension. The 2010 Cochrane update by Glynn et al 
found evidence of greater reduction of blood pressure with nurse led care but concluded 
that it required further evaluation,17 whilst our own focussed systematic review in the same 
year found some evidence to suggest that outcomes were improved when nurse prescribers 
were involved in some health care settings. We concluded however, that there was 
insufficient evidence to support widespread deployment of nurses in the management of 
hypertension.18 
In practice there has been shift in hypertension care over the last decade from doctors to 
nurses and health care assistants, and rising numbers of nurse prescribers are becoming 
active in hypertension.19 A multidisciplinary approach can improve control in resistant 
hypertension, and nurses record lower blood pressures than doctors due to smaller white 
coat effects,20-22 thus there seem good reasons to  involve nurses in hypertension care. In 
2003 Bengtson and Drevenhorn examined and identified the roles of nurses in hypertension 
care (box 1).23 In their review they called for further well designed studies to develop 
nursing care for hypertension, and over 50 randomised controlled trials have been 
published during the last 15 years. Within our current systematic review of allied health 
professional led care in hypertension we have reviewed evidence from randomised 
controlled trials that compare nurse led care with usual care (defined as doctor led care).24 
These are considered with relevant pooled findings in the following sections.  
 
 Team member or team leader 
 Measurement of blood pressure – avoiding white coat effect 
 Educator in non-pharmacological treatment 
 Translator for the physician with a holistic and psychosocial approach 
 Promoting lifestyle changes 
 Promoting medication adherence 
 Titrating blood pressure treatment to target 
 Monitoring and maintaining blood pressure treatment 
Box 1 – roles of the nurse in hypertension care; after Bengtson and Drevenhorn 200323 
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1.2.1 Settings for and subjects of interventions 
Hypertension is largely diagnosed and managed in primary care, and general or family 
practice settings have been the usual locations for studies of nurse led interventions.15,25-47. 
Trials have examined nurse led care in a variety of other settings, with evidence from 
individual randomised controlled trials for lower outcome blood pressures following 
delivery at home,48-53 in community centres,48,54-56 faith groups,57 community walking 
groups,58 and in secondary care clinics for hypertension,59 diabetes,60-63 cardiology,64,65 
stroke,66 or general medicine.67,68 Greater achievement of study blood pressure targets has 
also been demonstrated in workplace based interventions.14,69,70 Target achievement is less 
often improved within individual trials but pooled analyses confirm evidence of benefit from 
community settings (Odds ratio (OR) for target achievement with intervention 1.9 (95%CI 
1.2 to 3.0); 7 studies, 2820 participants),14,51,70-74 primary care settings (OR 1.4 (1.1 to 1.6); 
13 studies, 11278 participants),15,25,26,29,34,35,38,41,45,47,65,75,76 and secondary care settings (OR 
1.8 (1.3 to 2.5); 11 studies, 3605 participants).32,36,59-61,63,64,66,67,77,78 
Studies have found evidence of benefit for nurse led interventions from around the globe, 
thereby including a range of different ethnic populations. Culturally appropriate health 
education may improve outcomes in ethnic minorities,79 so some trials have specifically 
targeted ethnic subgroups regarded as underserved within their respective countries. 
Improved blood pressure lowering has been demonstrated in African American 
cohorts,25,34,35,37,42,48,54,56,67,71, American Hispanic people,42,67 First Nations American Indian 
people,49 Maoris,80 and South Asians.75,81. A substantial number of trials have focussed on 
control of hypertension with diabetes, suggesting that the findings summarised here can be 
applied to hypertensives with and without coincident diabetes.27,28,32,37,38,49,59-63,74-76,78,82,83 
Trials usually seek to recruit subjects with uncontrolled (i.e. above study or protocol target) 
blood pressures. Only a few studies have restricted recruitment to controlled hypertensives; 
although some have shown benefit,27,61 they are outweighed by those that fail to show 
improved blood pressure outcomes.34,61,82 Therefore the evidence summarised in this 
chapter should be viewed as relevant to populations with uncontrolled hypertension.  
 
1.2.2 Features of interventions 
1.2.2.1 Mode of review or follow up 
Interventions in randomised controlled trials usually include face to face contact with 
nurses, with or without other modalities. Nurse delivered telephone support for patients 
without face to face contact appears to be ineffective in delivering lower outcome blood 
pressures compared to usual care.25,26,28,34,35,37,52,66,77 Other trials have used telephone 
support to supplement face to face reviews,39,45,54,58,71,73,74 but on pooled analysis these 
show no superiority of systolic blood pressure outcomes compared to interventions based 
purely on face to face review,27,29,30,32,33,36,44,49-51,56,59,61,62,64,72,75,78,80,83-85 whilst mean 
reduction of diastolic pressures compared to usual care are actually greater for face to face 
interventions without telephone support than with it (-2.1mmHg (-3.0 to -1.2); 22 studies, 
7793 participants without telephone support vs. -0.9mmHg (-2.4 to 0.6); 7 studies, 2198 
participants; p=0.03). This pattern is also seen for achievement of study blood pressure 
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targets. These are complex interventions so caution is needed in interpreting these findings, 
however it may be that combined interventions, by using telephone consultations as a 
substitute for face to face interim reviews, reducing the frequency of face to face contact 
(see below). Whatever the cause we can conclude that the routine use of nurse led 
telephone support for blood pressure lowering is at least ineffective, and possibly 
counterproductive. 
1.2.2.2 Use of a management algorithm 
Our previous systematic review in 2010 found that effective nurse led interventions for 
hypertension require an algorithm to structure care.18 Taking account of newer studies 
differences in trial outcomes are no longer seen between studies using or not using an 
algorithm to structure care, however the quality of reporting of study methods varies.86 The 
majority of randomised trials of nurse led care do include an algorithm, and it is likely that, 
where not stated, other trials also had some structured care component. Structured care 
has emerged from previous reviews as an important component of effective 
interventions.87,88 Where treatment changes are explicit this may help to overcome clinical 
inertia,89 therefore a treatment algorithm remains an essential basis for nurse led care in 
hypertension.  
 
1.2.2.3 adherence/education/support  
Physicians recognise the importance of addressing medication non-adherence but less often 
actually do so.90 Many interventions include an element of education and lifestyle 
advice,56,60,64,67,71,74 or medication adherence support.48 These elements coupled with 
regular review are key components of effective long term care, to which the nurse-patient 
relationship is central.91 Education and explanation are key to improving medication 
adherence,92 which is often found to be higher in clinical trials than in routine care.93 
Education is usually only one element of a complex intervention in trials of nurse led care, 
so it is not clear from existing trials how important it is that any educational interventions 
for hypertension are delivered specifically by nurses. Evidence linking medication adherence 
and blood pressure outcomes is unclear.94 Existing trials have assessed medication 
adherence using questionnaires such as the Morisky scale,95 which are only modestly 
effective in detecting medication non-adherence in comparison to electronic pill box 
monitoring.96,97 Thus specific well designed studies using a robust method of adherence 
assessment are needed, to clarify whether nurse led educational interventions can be linked 
to improved medication adherence and better blood pressure outcomes. 
 
1.2.2.4 Home monitoring 
Self-monitoring of blood pressure alone,98 or with electronic transmission of results to 
physicians can improve blood pressure control,99,100 but the effect is enhanced when self-
monitoring is combined with additional support to the patient.101 Interventions including 
nurse monitoring and feedback on home blood pressure readings have proved effective 
compared to usual care.48,53 Home blood pressure readings are associated with lower 
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outcome blood pressures and greater achievement of study targets than clinic 
measurements.102 It is not clear whether this difference, in relation to nurse led care, can be 
wholly accounted for by the interventions themselves or may be confounded by differences 
due to setting and white coat effects:21 further evidence is required however the recently 
published TASMINH4 trial has confirmed the benefits of self-monitoring, with or without 
telemonitoring, when used by general practitioners to titrate antihypertensive medication in 
individuals with poorly controlled blood pressure.103 Further work is need to understand the 
role of the nurse in receiving, interpreting, and action upon patient measured blood 
pressure readings. 
 
1.2.2.5 Prescribing 
We have previously found greater reductions in blood pressure where interventions include 
nurse prescribing compared to continued prescribing by doctors, and documented a rising 
proportion of nurses prescribing in hypertension in our region over time.18,19 A more recent 
review of studies substituting prescribing by nurses or pharmacists for prescribing by 
doctors has also reported overall lower outcome blood pressures, although nurse-led care 
was not reported separately.104 On pooled analysis of randomised controlled trials there is a 
trend towards increasingly greater reductions in systolic but not diastolic blood pressure for 
interventions that include nurse prescribing (difference in change in systolic blood pressure -
6.4mmHg (-9.1 to -3.8); 10 studies, 4285 participants),32,49,53,59,60,67,71,74,78,105 compared to 
nurses advising changes to medication (-4.4mmHg (-6.2 to -2.6); 8 studies, 2522 
participants)25,29,51,56,61,73,77,82 or no nursing intervention for medication (-3.2mmHg (-5.3 to -
1.2); 32 studies, 9522 participants).26,28,30,31,33-37,39,40,44-48,50,52,54,58,62,64,66,68,72,73,75,80,81,83-85 
1.2.2.6 Frequency of and intensity of intervention 
There is marked variation in the frequency of face to face reviews of patients between trials, 
with greater reductions of systolic blood pressure for interventions that involve at least 
monthly contact until blood pressure reaches target (systolic reduction -7.2mmHg (-10.5 to -
3.9); 19 studies, 3760 participants)29,37,46,47,54,55,58,59,61,64,68,72,74,77,80,81,83,84 compared to less 
frequent interventions (-2.8mmHg (-3.8 to -1.8); 32 studies, 12523 participants; 
p=0.01).25,26,28,30-36,39,40,44-54,56,60,62,67,73,75,78,82,85 study blood pressure targets are also more 
frequently attained, compared to usual care, when interventions are delivered at least 
monthly (RR 1.5 (1.2 to 2.0); 12 studies, 2915 participants)14,29,47,55,59,61,64,66,70,72,74,77 
compared to less frequently (1.1 (1.0 to 1.2); 21 studies, 15011 participants; 
p=0.02).15,25,26,32,34-36,38,41,43,45,47,51,60,63,65,67,73,75,76,78 
By taking account of the interaction between the presence or absence of, and the frequency 
of, face to face to face interventions and the ability to change prescriptions, it is possible to 
demonstrate a hierarchy of effectiveness for nurse led interventions to lower blood 
pressure (fig 1; p<0.001 for subgroup differences). Interventions without face to face 
contact, themselves ineffective on pooled analysis, are enhanced by the ability to alter 
medications. The same is found for low frequency (less than monthly) face to face 
interventions, however greatest differences in blood pressure reductions for nurse led 
interventions compared to usual care are observed when face to face review occurs at least 
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monthly. Interestingly, at this level of intervention there seems to be no significant 
additional benefit in altering medications (systolic mean difference -8.6mmHg (-14.3 to -2.9) 
without medication change vs. -8.4mmHg (-13.0 to -3.7) with medication changes; p=0.95 
for differences), suggesting that frequent face to face reviews may be the most effective 
element of these interventions.  
We have found that frequent nurse led dose titration to achieve rapid control of blood 
pressure is both safe and feasible.106 A recent large retrospective study found that delays of 
greater than 1.4 months before intensifying treatment towards target were associated with 
higher risks of cardiovascular event or death over 10 years, hinting at the possibility that 
intensive interventions to control blood pressure quickly may have longer term benefits for 
outcomes.107 
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Figure 1. Changes in systolic blood pressure for nurse led interventions compared to usual care 
grouped by intensity of intervention. 
Study or Subgroup 
Not face to face, no treatment change 
Bosworth 2009 
Bosworth 2009a 
Contreras 2005 
Kerry 2013 
Mackenzie 2013 
Odnoletkova 2016 
Subtotal (95% CI) 
Heterogeneity: Tau² = 28.94; Chi² = 60.86, df = 5 (P < 0.00001); I² = 92% 
Test for overall effect: Z = 0.04 (P = 0.97) 
Not face to face, treatment change included 
Bosworth 2011a 
Brennan 2010 
Crowley 2013 
Rudd 2004 
Wakefield 2011 
Wakefield 2011 
Subtotal (95% CI) 
Heterogeneity: Tau² = 12.93; Chi² = 27.96, df = 5 (P < 0.0001); I² = 82% 
Test for overall effect: Z = 1.86 (P = 0.06) 
Face to face less than monthly, no treatment change 
Amado 2011 
Artinian 2007 
Bebb 2007 
Bellary 2008 
Bogner 2013 
Chiu 2010 
Hornnes 2011 
Jolly 1999 
Kastarinen 2002 
Kastarinen 2002 
Ko 2004 
Pezzin 2011 
Schroeder 2005 
Sen 2013 
Ulm 2010 
Woollard 1995 
Woollard 2003 
Zhu 2014 
Subtotal (95% CI) 
Heterogeneity: Tau² = 0.05; Chi² = 17.39, df = 17 (P = 0.43); I² = 2% 
Test for overall effect: Z = 2.95 (P = 0.003) 
Face to face less than monthly, treatment change included 
Ali 2011 
Becker 2005 
Hebert 2011 
MacMahon 2009 
New 2003 
Pezzin 2011 
Tobe 2006 
Subtotal (95% CI) 
Heterogeneity: Tau² = 9.55; Chi² = 30.52, df = 6 (P < 0.0001); I² = 80% 
Test for overall effect: Z = 3.13 (P = 0.002) 
Face to face monthly or more, no treatment change 
Alhalaiqa 2011 
Artinian 2001 
Artinian 2001 
Garcia-Pena 2001 
Hotu 2010 
Lee 2007 
McHugh 2001 
McKee 2011 
O'Hare 2004 
Tonstad 2007 
Woollard 1995 
Woollard 2003 
Subtotal (95% CI) 
Heterogeneity: Tau² = 86.92; Chi² = 158.12, df = 11 (P < 0.00001); I² = 93% 
Test for overall effect: Z = 2.97 (P = 0.003) 
Face to face monthly or more, treatment change included 
Allen 2011 
Dean 2014 
Denver 2003 
Janssen 2009 
Taylor 2003a 
Wallymahmed 2011 
Subtotal (95% CI) 
Heterogeneity: Tau² = 25.81; Chi² = 57.37, df = 5 (P < 0.00001); I² = 91% 
Test for overall effect: Z = 3.49 (P = 0.0005) 
Total (95% CI) 
Heterogeneity: Tau² = 17.99; Chi² = 514.45, df = 54 (P < 0.00001); I² = 90% 
Test for overall effect: Z = 6.08 (P < 0.00001) 
Test for subgroup differences: Chi² = 21.59, df = 5 (P = 0.0006), I² = 76.8% 
IV, Random, 95% CI 
2.40 [-3.01, 7.81] 
0.90 [-2.09, 3.89] 
-9.50 [-12.05, -6.95] 
-2.70 [-5.71, 0.31] 
24.00 [13.52, 34.48] 
-3.00 [-5.00, -1.00] 
0.09 [-4.60, 4.78] 
-2.00 [-5.23, 1.23] 
-3.40 [-5.35, -1.45] 
2.90 [0.48, 5.32] 
-8.50 [-14.52, -2.48] 
-8.20 [-13.27, -3.13] 
-2.54 [-7.47, 2.39] 
-3.12 [-6.43, 0.18] 
0.55 [-1.95, 3.05] 
-4.00 [-7.00, -1.00] 
-0.10 [-1.47, 1.27] 
-0.50 [-1.94, 0.94] 
-4.80 [-10.84, 1.24] 
-11.06 [-20.27, -1.85] 
-0.60 [-6.36, 5.16] 
-1.20 [-3.37, 0.97] 
-1.30 [-4.49, 1.89] 
-2.40 [-4.77, -0.03] 
-1.00 [-4.84, 2.84] 
-1.60 [-4.90, 1.70] 
-1.70 [-5.13, 1.73] 
3.20 [-6.12, 12.52] 
-4.40 [-10.43, 1.63] 
-2.00 [-11.71, 7.71] 
-1.10 [-7.66, 5.46] 
-0.40 [-4.03, 3.23] 
-1.04 [-1.72, -0.35] 
2.00 [-2.29, 6.29] 
-6.00 [-8.22, -3.78] 
-7.70 [-14.16, -1.24] 
-12.20 [-17.48, -6.92] 
-2.00 [-3.17, -0.83] 
-2.00 [-5.14, 1.14] 
-7.00 [-13.55, -0.45] 
-4.42 [-7.19, -1.66] 
-23.10 [-25.75, -20.45] 
-14.00 [-27.64, -0.36] 
-25.70 [-37.67, -13.73] 
-3.30 [-6.31, -0.29] 
-9.00 [-15.82, -2.18] 
-7.00 [-11.49, -2.51] 
-9.10 [-13.72, -4.48] 
-3.90 [-9.80, 2.00] 
-4.60 [-13.05, 3.85] 
0.00 [-3.88, 3.88] 
-4.00 [-15.22, 7.22] 
-3.30 [-9.77, 3.17] 
-8.60 [-14.27, -2.92] 
-6.20 [-10.24, -2.16] 
-5.40 [-9.98, -0.82] 
-11.00 [-36.49, 14.49] 
-14.00 [-16.58, -11.42] 
-4.20 [-4.95, -3.45] 
-12.00 [-17.65, -6.35] 
-8.35 [-13.04, -3.66] 
-4.05 [-5.35, -2.74] 
Mean Difference Mean Difference 
IV, Random, 95% CI 
-20 -10 0 10 20 
Favours intervention Favours usual care 
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1.3 Costs and cost effectiveness of interventions 
Costs of nurse led interventions are infrequently reported as primary outcome measures. 
Costs will be dependent on the health care system in which the interventions are based, 
however data were only identified from trials in the UK,44,75 USA35,55,73,77,108 and one group in 
Canada.69,70 With one exception, a trial of workplace based nurse interventions,69 costs are 
higher for nurse led care compared to usual (doctor led) care. Excess costs per patient per 
year ranged from $212 to $1153 per patient per year, representing between 1.18 and 1.87 
times the costs of usual care. There is no clear association between the costs of 
interventions and either their intensity or their efficacy in reducing blood pressure. 
Therefore it is difficult to estimate the cost effectiveness of nurse led interventions. One UK 
trial reported an incremental cost effectiveness ratio per quality adjusted life year of 
£28.983;75 this exceeds the £20,000 implementation cost threshold set by the UK National 
Institute for Health and Care Excellence.109 
1.4 Clinical implications 
The findings of individual trials and systematic reviews summarised here offer some 
guidance for the design of a successful nurse led programme for care in hypertension. 
Contacts should be face to face, occurring at least monthly until blood pressure reaches 
target. They should include the ability to either prescribe, or advise the doctor to prescribe, 
changes in blood pressure lowering medications and be guided by a structured stepped care 
algorithm. Lowering of systolic blood pressure by 5mmHg has been estimated to lead to 
14% fewer deaths from stroke, 9% fewer deaths from CHD, and 7% fewer deaths overall.110  
These levels of reduction are exceeded by the most intensive nurse led interventions so are 
clinically as well as statistically important. 
There are clinical reasons to favour rapid and effective control of blood pressure; arterial 
stiffness, a marker of target organ damage, improves in newly diagnosed and treated 
hypertensives according to the intensity of BP lowering achieved.111 Similarly post hoc 
findings from the VALUE trial found that blood pressure response within one month of 
treatment predicted a persistent advantage for the combined outcome of cardiac events, 
stroke or death,112,113 and post hoc analysis of the Syst-Eur trial provided additional 
evidence for improved outcomes in cardiovascular event reduction for initial dual rather 
than monotherapy, in association with greater blood pressure reduction.114 The FEVER study 
also suggests superior outcomes for early attainment of blood pressure control in a Chinese 
population.115 None of these findings, however, relate directly to nurse led interventions to 
control blood pressure, and evidence for long term differences in outcome for nurse led 
care is currently lacking. 
Extrapolation of trial findings into day to day practice cannot be assumed. Little is known 
about the acceptability of substitution of nurse led for doctor led care in hypertension. 
Exploratory findings in our locality suggest that the concept is broadly acceptable to 
patients,116 as is the case for nurse prescribing in diabetes, a condition often associated with 
hypertension.117 However despite good trial evidence for improved blood pressure lowering 
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with nurse prescribing we could not confirm this benefit in a recent analysis of routine 
primary care data from our region.19 
1.5 Research implications 
In trials (and in practice) nurses often work in conjunction with other members of the 
primary health care team such as community health workers, health care assistants,19 
pharmacists and doctors.118 Many trials provide evidence for improved outcomes with 
pharmacist led care119 but few have examined a team approach utilising both nurses’ and 
pharmacists’ expertise.120,121  Community health workers or lay workers have sometimes 
been included in trials of interventions,56,71 often in low resource settings or with a specific 
role in link working with specific ethnic groups who may experience barriers to accessing 
healthcare.80,81 Studies suggest that teams can facilitate self-management,122 and a recent 
survey of routine primary care data in our region has documented the increasing 
involvement of health care assistants in team approaches to hypertension care with better 
attainment of the English national Quality and Outcomes Framework blood pressure 
target.19,123 Future studies need to examine team based approaches that make best use of 
existing professionals’ and multi-disciplinary teams’ skills, thus facilitating adoption into 
existing care structures; some such studies are underway.124,125 
The available evidence suggests that future trials should abandon telephone support as a 
component of any intervention, however internet or other telehealth systems may show 
benefits.82,126,127 It is possible that nurses may enhance the benefits of home or tele 
monitoring but their specific role and contribution requires further study.101,128  
It seems clear that any prospective study design should be resourced for at least a monthly 
face to face review until blood pressure control is achieved, and should include the ability o 
prescribe or alter medication according to a stepped care algorithm. Depending on study 
setting a careful study design will be required to mitigate the effects of setting (home vs 
clinic) and personnel (nurse vs doctor vs pharmacist) on white coat effects to minimise bias. 
Ideally future studies will be designed and powered to measure costs and cost effectiveness 
of interventions, and measure satisfaction and treatment effects using validated tools. 
International blood pressure guideline targets are starting to be cut in response to evidence 
from SPRINT and other recent studies.129-132 Currently evidence of greater blood pressure 
lowering only exists for nurse led care down to, but not below, 130mmHg systolic in the 
context of comorbidities such as diabetes or secondary prevention of cardiovascular and 
cerebrovascular disease.25,49,52,60,61,74,75,82,83 It will be important to test nurse led 
interventions that aim to cut blood pressure to lower more stringent potential targets in 
primary prevention, to discover whether the existing evidence can be extrapolated.  
The reporting of harms from nurse led intervention studies is negligible. Although such 
interventions are expected to offer a low risk of adverse events this should be confirmed by 
robust reporting and inclusion of quality of life and satisfaction scales in future studies. 
Again the implications of increased adverse events seen in trials aiming to lower blood 
pressure below 130mmHg will have to be taken into account.129,133 
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1.6 Conclusions 
There is good evidence to suggest that nurse led interventions can achieve greater blood 
pressure reductions and achievement of blood pressure targets than usual care. Reviewing 
patients at least monthly, and changing medication according to a stepped care protocol are 
shown to be important elements of such interventions. Inclusion of nurses as members or 
leaders of teams intervening to control blood pressure should be effective but requires 
further study. Costs and cost benefits of interventions are poorly described and there are no 
reports of long term effects of outcomes. The ability of nurse led services to adopt new 
lower blood pressure targets safely may be assumed but cannot currently be demonstrated. 
Areas for future research are identified. 
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